Aller au contenu principal
Profil bibliographique

Mafalda Alpoim

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

4Publications signalées
11Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchHepatitis C virus researchRheumatoid Arthritis Research and TherapiesAcute Myeloid Leukemia Research

Les publications récentes

Accès ouvert 2025 article OpenAlex

Analysis of Stereotyped B-Cell Receptor Frequencies Among Portuguese De Novo-Diagnosed Chronic Lymphocytic Leukemia Patients (PAIS Study)

Daniela Alves, Gisela Ferreira, Joana Caldas, Mariana de Souza Fernandes et autres

Background/Objectives: Chronic lymphocytic leukemia (CLL) exhibits a heterogeneous clinical course influenced by genetic factors, such as the mutational status of immunoglobulin variable regions (IGHV). Recently, B-cell receptor (BcR) stereotypes have shown promising prognostic value, potentially surpassing IGHV status. The PAIS study analyzed …

pt (code pays fourni par la source)

1 citation Cancers
Accès ouvert 2021 article OpenAlex

Hepatic Infiltration by Splenic Marginal Zone Lymphoma in a Patient With Cured Hepatitis C

Leonor P. Silva, Mafalda Alpoim, Ana Cristina de Medeiros Ribeiro, Pedro Caiano Gil et autres

Splenic marginal zone lymphoma (SMZL) accounts for only 1-2.7% of all lymphomas. Almost all patients have bone marrow (BM) involvement but only one-third has liver involvement. The higher prevalence of hepatitis C virus (HCV) infection in these patients has led to the …

pt (code pays fourni par la source)

0 citations Cureus
Accès ouvert 2016 article OpenAlex

Clinical outcomes of AML patients treated with Azacitidine in Portugal: A retrospective multicenter study

Antonio Medina Almeida, Ana Rita Ferreira, María João Costa, Sofia Silva et autres

Retrospective data was collected from 77 elderly acute myeloid leukemia (AML) patients treated with Azacitidine (AZA) and 50 elderly AML patients treated with intensive chemotherapy (IC) from 4 Portuguese Hospitals. Median OS was 10.6 months in those receiving AZA as 1st line. …

pt (code pays fourni par la source)

7 citations Leukemia Research Reports

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.